High-power electron beam tests of a liquid-lithium target and characterization study of 7Li(p,n) near-threshold neutrons for accelerator-based boron neutron capture therapy

Halfon, S.; Paul, M.; Arenshtam, A.; Berkovits, D.; Cohen, D.; Eliyahu, I.; Kijel, D.; Mardor, I.; Silverman, I.

doi:10.1016/j.apradiso.2013.11.043

Cited by 11 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Beryllium can be used as a static target with or without beam rasterring [22,23,24], or in a rotating configuration [25]. Lithium can be solid for relatively low power [26,27] or flowing liquid for high power, with or without a window [28,29,30,31,32].…”

Section: Windowless Jet Liquid Lithium Targetmentioning

confidence: 99%

“…More information about LiLiT and its supporting systems (electro-magnetic pump, heat exchangers, control, etc.) can be found in [30,31,33,35,37].…”

Section: Windowless Jet Liquid Lithium Targetmentioning

confidence: 99%

“…The 10 B dose created by near threshold 7 Li(p,n) neutrons was simulated by Monte-Carlo methods and was measured by irradiating 10 B samples sandwiched between CR-39 nuclear track detectors, inside a water filled phantom, simulating human tissue. The treatment dose was deduced by counting the  and 7 Li tracks produced by in the CR-39 by 10 B(n,) 7 Li [31].…”

Section: Accelerator Based Boron Neutron Capture Therapymentioning

confidence: 99%

See 2 more Smart Citations

The Soreq Applied Research Accelerator Facility (SARAF): Overview, research programs and future plans

Mardor¹,

Aviv²,

Avrigeanu³

et al. 2018

Eur. Phys. J. A

View full text Add to dashboard Cite

The Soreq Applied Research Accelerator Facility (SARAF) is under construction in the Soreq Nuclear Research Center at Yavne, Israel. When completed at the beginning of the next decade, SARAF will be a user facility for basic and applied nuclear physics, based on a 40 MeV, 5 mA CW proton/deuteron superconducting linear accelerator. Phase I of SARAF (SARAF-I, 4 MeV, 2mA CW protons, 5 MeV 1mA CW deuterons) is already in operation, generating scientific results in several fields of interest. The main ongoing program at SARAF-I is the production of 30 keV neutrons and measurement of Maxwellian Averaged Cross Sections (MACS), important for the astrophysical s-process. The world leading Maxwellian epithermal neutron yield at SARAF-I (5×10 10 epithermal neutrons/sec), generated by a novel Liquid-Lithium Target (LiLiT), enables improved precision of known MACSs, and new measurements of lowabundance and radioactive isotopes. Research plans for SARAF-II span several disciplines: Precision studies of beyond-Standard-Model effects by trapping light exotic radioisotopes, such as 6 He, 8 Li and 18,19,23 Ne, in unprecedented amounts (including meaningful studies already at SARAF-I); extended nuclear astrophysics research with higher energy neutrons, including generation and studies of exotic neutron-rich isotopes relevant to the rapid (r-) process; nuclear structure of exotic isotopes; high energy neutron cross sections for basic nuclear physics and material science research, including neutron induced radiation damage; neutron based imaging and therapy; and novel radiopharmaceuticals development and production.

show abstract